StockData
Ascentage Pharma Group International logo

Ascentage Pharma Group International (AAPG) stock

AAPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 3/30
$13.01−0.13 (-0.97%)

Close on Nov 18, 2026Market cap $1.21BP/E –Yield –

Ascentage Pharma Group International revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was CN¥574.12M, down 41.5% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025CN¥574.12M-41.5%
FY2024Dec 31, 2024CN¥980.65M+341.8%
FY2023Dec 31, 2023CN¥221.98M+5.9%
FY2022Dec 31, 2022CN¥209.71M–

More Ascentage Pharma Group International figures

See a number that looks wrong?